| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/03009749509095161 |
| P698 | PubMed publication ID | 8533039 |
| P2093 | author name string | Szechtman H | |
| Denburg JA | |||
| Carbotte RM | |||
| Denburg SD | |||
| Sakić B | |||
| P2860 | cites work | Plasma-Cell Dyscrasia and Peripheral Neuropathy with a Monoclonal Antibody to Peripheral-Nerve Myelin | Q54212370 |
| A Controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus | Q57740739 | ||
| Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus | Q57740770 | ||
| Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1 | Q59094881 | ||
| Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3) | Q33364820 | ||
| Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies | Q33388194 | ||
| Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients | Q33406476 | ||
| Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies | Q33555845 | ||
| Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus | Q33562233 | ||
| Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. | Q33562378 | ||
| Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus | Q33562546 | ||
| Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus | Q33592040 | ||
| Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement | Q33629959 | ||
| Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice | Q34015304 | ||
| Brain abnormalities in immune defective mice | Q34348855 | ||
| Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus | Q35197902 | ||
| Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological | Q35256938 | ||
| Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells | Q35600755 | ||
| Platelet glycoproteins Ia, Ic, and IIa are physicochemically indistinguishable from the very late activation antigens adhesion-related proteins of lymphocytes and other cell types | Q35809833 | ||
| Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein | Q36231689 | ||
| Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients | Q36355152 | ||
| The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome | Q36355919 | ||
| The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus | Q36722914 | ||
| Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice | Q36788212 | ||
| Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus | Q37623504 | ||
| Antiphospholipid antibodies: more than just a disease marker? | Q37920692 | ||
| Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE) | Q38660157 | ||
| Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus | Q39485237 | ||
| Autoimmunity in demyelinating diseases | Q39550553 | ||
| Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis | Q39550559 | ||
| Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977 | Q39884813 | ||
| Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
| Dissecting aortic aneurysm in systemic lupus erythematosus | Q40536916 | ||
| Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients | Q40687864 | ||
| Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal | Q40725670 | ||
| Interferon-alpha in lupus psychosis | Q41092098 | ||
| Psychiatric disorder and cognitive impairment in systemic lupus erythematosus | Q41120214 | ||
| Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome | Q41238775 | ||
| Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity | Q41274152 | ||
| Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus | Q41354340 | ||
| Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus | Q41418650 | ||
| Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice | Q41516447 | ||
| Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus | Q41649332 | ||
| Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis | Q43918124 | ||
| A behavioral profile of autoimmune lupus-prone MRL mice | Q44070194 | ||
| Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behavior and autoimmunity | Q44109146 | ||
| Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
| Association of human immunodeficiency virus infection and autoimmune phenomena | Q45832998 | ||
| Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis | Q46376254 | ||
| Interleukin-1 immunoreactive innervation of the human hypothalamus | Q48088092 | ||
| Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning | Q48115666 | ||
| Behavior and immune status of MRL mice in the postweaning period | Q48168631 | ||
| Antibodies to brain integral membrane proteins in systemic lupus erythematosus | Q48286054 | ||
| Spatial learning during the course of autoimmune disease in MRL mice | Q48318067 | ||
| Antiserum to brain gangliosides produces recurrent epileptiform activity | Q48350462 | ||
| Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury | Q48413747 | ||
| Effect of passive transfer of anti-brain antibodies to a normal recipient | Q48458439 | ||
| Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus | Q48473651 | ||
| Environmental enrichment, neocortical ectopias, and behavior in the autoimmune NZB mouse | Q48479273 | ||
| Cytokine expression in the brain during the acquired immunodeficiency syndrome | Q48496332 | ||
| Behavior, ectopias and immunity in BD/DB reciprocal crosses | Q48529831 | ||
| Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings | Q48612694 | ||
| Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers | Q48752879 | ||
| Serum lymphocytotoxic antibodies in neuropsychiatric lupus: a serial study | Q48764029 | ||
| Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice | Q48794452 | ||
| Neocortical VIP neurons are increased in the hemisphere containing focal cerebrocortical microdysgenesis in New Zealand Black mice | Q48860116 | ||
| Antineuronal antibodies in systemic lupus erythematosus | Q48925446 | ||
| Disturbed emotionality in autoimmune MRL-lpr mice. | Q51131575 | ||
| Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. | Q51131677 | ||
| Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. | Q51186886 | ||
| Effect of intraventricular injection of anti-brain antibody on defensive conditioned reflexes. | Q51186973 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 263-273 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
| P1476 | title | Nervous system lupus: pathogenesis and rationale for therapy | |
| P478 | volume | 24 |
| Q47854545 | Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis |
| Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
| Q24200954 | Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus |
| Q24246092 | Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus |
| Q45974307 | Hydrocephalus in an elderly man with systemic lupus erythematosus. |
| Q48322858 | Nervous system lupus mimics limbic encephalitis |
| Q34459628 | Neuropsychiatric Symptoms in Lupus |
| Q44316147 | Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study). |
| Q48221017 | Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction |
| Q48770967 | Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. |
| Q50501459 | Study of systemic lupus erythematosus in temporal bones. |
| Q39596714 | Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus |
| Q34248439 | Systemic lupus erythematosus presenting as subacute delirium in an 82-year-old woman. |
| Q30476952 | The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus |
| Q55514340 | The association between systemic lupus erythematosus and dementia A meta-analysis. |
Search more.